Device Trial Radar · NCT07089576
Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA
Last checked: Nov 20, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
132
Planned (sponsor's estimate)
Start
Nov 4, 2025
Primary completion
Apr 2028
Study completion Jul 2032
Sponsor
- Lead sponsor
- Artivion Inc.Public (AORT)
- Sponsor type
- Industry
- Collaborators
- Bright Research Partners
- First posted
- Jul 28, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn if the Arcevo LSA stent graft can safely and effectively treat patients that have an acute or chronic aortic dissection and/or aneurysm that involves the aortic arch and the descending thoracic aorta, with or without the involvement of the ascending aorta.
Conditions
- Aortic Arch Aneurysm
- Aortic Arch Dissection
- Chronic Aortic Dissection
- Acute Aortic Dissection
Interventions
Arcevo™ LSA Hybrid Stent Graft SystemDevice
The Arcevo LSA Hybrid Stent Graft System is an implantable aortic stent graft with LSA branch which is preloaded onto a delivery system and implanted during an open surgical procedure, or more specifically a total arch replacement procedure. The device is intended for use with a proximal surgical graft (not supplied). If additional coverage is needed, a protocol specified thoracic endovascular aortic repair (TEVAR) device may be used.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite Rate of Patients Free From ≥1 Major Adverse EventTime frame: 1 year post-index procedure of LSA stent graft implant
Locations
26 sites in 3 countries. Site status is shown where the registry gives one.
University of Alabama
Birmingham, Alabama · Recruiting
25 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.